These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 32410504)
21. Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Tejera E; Munteanu CR; López-Cortés A; Cabrera-Andrade A; Pérez-Castillo Y Molecules; 2020 Nov; 25(21):. PubMed ID: 33172092 [TBL] [Abstract][Full Text] [Related]
33. Discovery of novel inhibitors of SARS-CoV-2 main protease. Zheng L; Chen Y; Bao J; He L; Dong S; Qi Y; Zhang JZH J Biomol Struct Dyn; 2022; 40(23):12526-12534. PubMed ID: 34472424 [TBL] [Abstract][Full Text] [Related]
34. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy. Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346 [TBL] [Abstract][Full Text] [Related]
35. Pea eggplant ( Govender N; Zulkifli NS; Badrul Hisham NF; Ab Ghani NS; Mohamed-Hussein ZA PeerJ; 2022; 10():e14168. PubMed ID: 36518265 [TBL] [Abstract][Full Text] [Related]
36. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation. Prajapati J; Patel R; Goswami D; Saraf M; Rawal RM Comput Biol Med; 2021 Aug; 135():104568. PubMed ID: 34174757 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2. Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149 [TBL] [Abstract][Full Text] [Related]
38. Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M Ahamad S; Kanipakam H; Birla S; Ali MS; Gupta D Eur J Pharmacol; 2021 Jan; 890():173664. PubMed ID: 33131721 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach. El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152 [TBL] [Abstract][Full Text] [Related]
40. A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease. Mandour YM; Zlotos DP; Alaraby Salem M J Biomol Struct Dyn; 2022 Mar; 40(5):2327-2338. PubMed ID: 33094680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]